| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M SAXAGLIPTIN (is an active metabolite)
| SAXAGLIPTIN |
ANTIDIABETIC | - | Cmax 149 NANOMOLAR (5 MILLIGRAM) VD 61 LITER (EQN) PPB 0 PERCENT Cl 13.8 LITER / HOUR HT 3.1 HOUR | DIPEPTIDYL PEPTIDASE-4 (DPP-4) | Dipeptidyl peptidase 4 UNIPROT P27487 DPP4 more at DrugCentral | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that the equation t1/2 = VD / Cl * 0.693 was used | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| SAXAGLIPTIN (has an active metabolite)
| SAXAGLIPTIN |
ANTIDIABETIC | ORAL | Cmax 76 NANOMOLAR (5 MILLIGRAM) VD 49.7 LITER (EQN) PPB 0 PERCENT Cl 13.8 LITER / HOUR HT 2.5 HOUR SOLUBILITY SPARINGLY SOLUBLE IN WATER | DIPEPTIDYL PEPTIDASE-4 (DPP-4) | Dipeptidyl peptidase 4 UNIPROT P27487 DPP4 more at DrugCentral | EMA | |||
